Shan, W.; Dai, C.; Zhang, H.; Han, D.; Yi, Q.; Xia, B.
ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway. Cancers 2022, 14, 5704.
https://doi.org/10.3390/cancers14225704
AMA Style
Shan W, Dai C, Zhang H, Han D, Yi Q, Xia B.
ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway. Cancers. 2022; 14(22):5704.
https://doi.org/10.3390/cancers14225704
Chicago/Turabian Style
Shan, Wulin, Chunyang Dai, Huanhuan Zhang, Dan Han, Qiyi Yi, and Bairong Xia.
2022. "ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway" Cancers 14, no. 22: 5704.
https://doi.org/10.3390/cancers14225704
APA Style
Shan, W., Dai, C., Zhang, H., Han, D., Yi, Q., & Xia, B.
(2022). ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway. Cancers, 14(22), 5704.
https://doi.org/10.3390/cancers14225704